首页> 外文期刊>Clinical Endocrinology >Treatment of paediatric hyperthyroidism but not hypothyroidism has a significant effect on weight.
【24h】

Treatment of paediatric hyperthyroidism but not hypothyroidism has a significant effect on weight.

机译:小儿甲状腺功能亢进症的治疗对体重没有显着影响,而甲状腺功能减退症则不行。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: Thyroid hormones are involved in metabolic regulation, but the degree to which they affect body weight and body mass index (BMI) in children is unclear. We examined the effect of hypo- and hyperthyroidism on weight and BMI at the time of diagnosis and after appropriate treatment. DESIGN: Prospective and retrospective case series. PATIENTS: Children referred for thyroid dysfunction were enrolled prospectively if their total or free T4 was elevated with TSH <0.05 mIU/ml (N = 57) or if they had a subnormal total or free T4 and TSH >20 (N = 29). RESULTS: Almost all patients had at least 2 classic signs or symptoms including goitre, but hyperthyroid patients had more symptoms. Mean BMI z scores at the time of diagnosis did not significantly differ between the two groups. Males with hyperthyroidism complained of weight loss more frequently and had a lower pretreatment BMI z score than hyperthyroid females. Hypothyroid patients lost a minimal amount of weight by the first follow-up (mean of 0.3 kg) and on average gained weight by the second follow-up visit. In contrast hyperthyroid patients gained a mean of 3.4 kg at the first follow-up visit and a mean of 7.1 kg by the second. CONCLUSIONS: Correction of hypothyroidism resulted in minimal weight loss, suggesting that hypothyroidism does not cause significant weight gain in children. In contrast, correction of the hyperthyroid state had a somewhat greater impact on weight status. These results are consistent with prior reports but surprising given the opposite metabolic effects of hypo- and hyperthyroidism.
机译:目的:甲状腺激素参与代谢调节,但是它们影响儿童体重和体重指数(BMI)的程度尚不清楚。在诊断时和适当治疗后,我们检查了甲状腺功能减退和甲亢对体重和BMI的影响。设计:前瞻性案例和回顾性案例系列。患者:如果甲状腺功能异常的儿童的总或游离T4升高且TSH <0.05 mIU / ml(N = 57),或者总或游离T4低于正常值且TSH> 20(N = 29),则前瞻性入组。结果:几乎所有患者都有至少2种典型体征或症状,包括甲状腺肿,但甲状腺功能亢进患者的症状更多。两组在诊断时的平均BMI z得分无显着差异。与甲状腺功能亢进的女性相比,患有甲状腺功能亢进的男性抱怨体重减轻的频率更高,并且治疗前的BMI z评分更低。甲状腺功能减退患者在第一次随访中体重减轻最小(平均0.3 kg),而在第二次随访中体重平均增加。相反,甲状腺功能亢进患者在第一次随访中平均增加了3.4千克,在第二次随访中平均增加了7.1千克。结论:甲状腺功能减退症的纠正导致体重减轻最小,这表明甲状腺功能减退症不会引起儿童体重的显着增加。相反,甲状腺功能亢进状态的校正对体重状态的影响更大。这些结果与先前的报道一致,但是由于甲状腺功能低下和甲状腺功能亢进的相反的代谢作用而令人惊讶。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号